Coleus (Forskolin) (Coleus forskohlii)
What Is Coleus (Forskolin)?
Coleus (Forskolin) is listed botanically as Coleus forskohlii, a plant of the Lamiaceae family, native to India, Nepal and East Africa. The material in circulation is root — an underground part, harvested once the plant has drawn its reserves down. The common name Coleus (Forskolin) and the botanical name Coleus forskohlii refer to the same material, and labels may use either — a detail that matters when related species in the same genus are not interchangeable. Its character is described as mildly minty, earthy, slightly bitter, which is often how the raw material is checked for quality.
In Ayurveda, Coleus (Forskolin) is a long-standing entry. It is recorded in the Sanskrit compendia of Ayurveda, where plants were classified by taste (rasa), potency (virya) and post-digestive effect (vipaka), and it remains in continuous household and clinical use across South Asia. Beyond its practical use it carries cultural associations — Ayurvedic Makandi — used for opening blocked channels and associated with transformation and cellular renewal.
Today most searches for Coleus (Forskolin) come from people reading about lung support, energy, muscle recovery and eye health, or checking how it sits alongside a medication they already take. The use most often documented in the literature is forskolin directly activates adenylate cyclase — increases cAMP, followed by reduces intraocular pressure in glaucoma studies.
How Does Coleus (Forskolin) Work?
Coleus (Forskolin) works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in root rather than by one marker molecule.
Ayurvedic classification turns on rasa, virya and dosha: what the plant tastes like, whether it heats or cools, and which constitution it suits. That older description was arrived at without chemistry, and it does not map neatly onto constituent names — but it records centuries of observation about dose, preparation and who the plant suited.
The research base is developing: there are human trials, though sample sizes and designs vary, and this profile cites 2 sources. Reported findings centre on forskolin mechanism well-characterized. Where research exists, it examines forskolin directly activates adenylate cyclase — increases cAMP, reduces intraocular pressure in glaucoma studies and bronchodilatory — relaxes airway smooth muscle. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into water and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
Coleus (Forskolin) is studied as a whole preparation because isolating one fraction tends to behave differently from the material it was taken out of — a recurring finding across the plant-chemistry literature.
Because these constituents are processed by the same pathways that handle many medicines, Coleus (Forskolin) is documented as interacting with antihypertensives and anticoagulants. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Coleus (Forskolin) can differ substantially; this is why reference entries specify root and, where they exist, standardisation markers.